| 1 |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].
Lancet,
2020,
395(10223): 507-513.
|
| 2 |
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [J].
JAMA Intern Med,
2020,
180(7): 934-943.
|
| 3 |
Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID-19 [J].
Ann Intern Med,
2020,
173(12): 1030.
|
| 4 |
Angus DC, van der Poll T. Severe sepsis and septic shock [J].
N Engl J Med,
2013,
369(9): 840-851.
|
| 5 |
Zhou Y, Fu B, Zheng X, et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients [J].
Natl Sci Rev,
2020,
7(6): 998-1002.
|
| 6 |
Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm [J].
Immunotherapy,
2016,
8(8): 959-970.
|
| 7 |
Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [J].
Thromb Res,
2020,
191: 145-147.
|
| 8 |
Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy [J].
Thromb Res,
2020,
191: 9-14.
|
| 9 |
Thrombosis and Hemostasis Group, Hematology Society of Chinese Medical Association. Consensus of Chinese experts on diagnosis of disseminated intravascular coagulation (version 2017) [J].
Zhonghua Xue Ye Xue Za Zhi,
2017,
38(5): 361-363.
|
| 10 |
Gando S, Iba T, Eguchi Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria [J].
Crit Care Med,
2006,
34(3): 625-631.
|
| 11 |
Taylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation [J].
Thromb Haemost,
2001,
86(5): 1327-1230.
|
| 12 |
Iba T, Nisio MD, Levy JH, et al. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey [J].
BMJ Open,
2017,
7(9): e017046.
|
| 13 |
China National Health Commission. Diagnosis and treatment of novel coronavirus pneumonia in China (trial version 7) [EB/OL]. [2020-3-3].
URL
|
| 14 |
Liu Q, Wang RS, Qu GQ, et al. Gross examination report of a COVID-19 death autopsy [J].
Fa Yi Xue Za Zhi,
2020,
36(1): 21-23.
|
| 15 |
Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation [J].
Lancet Respir Med,
2020,
8(6): e46-e47.
|
| 16 |
Xu Y, Zhu R, Sun Y, et al. Antithrombin Ⅲ for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients [J].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,
2017,
29(2): 127-132.
|
| 17 |
Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia [J].
J Thromb Haemost,
2020,
18(4): 844-847.
|
| 18 |
Shorr AF, Thomas SJ, Alkins SA, et al. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients [J].
Chest,
2002,
121(4): 1262-1268.
|
| 19 |
Owings JT, Gosselin RC, Anderson JT, et al. Practical utility of the D-dimer assay for excluding thromboembolism in severely injured trauma patients [J].
J Trauma,
2001,
51(3): 425-430.
|
| 20 |
Wang Z, Li X, Zhu R, et al. A reevaluation of diagnostic efficacy of International Society of Thrombosis and Haemostasis and Japanese Association for Acute Medicine criteria for the diagnosis of sepsis disseminated intravascular coagulation [J].
Zhonghua Nei Ke Za Zhi,
2019,
58(5): 355-360.
|
| 21 |
Semeraro F, Ammollo CT, Caironi P, et al. D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis [J].
Blood Transfus,
2020,
18(4): 304-311.
|
| 22 |
Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 [J].
J Thromb Haemost,
2020,
18(6): 1324-1329.
|
| 23 |
Gando S, Levi M, Toh CH. Disseminated intravascular coagulation [J].
Nat Rev Dis Primers,
2016,
2: 16037.
|
| 24 |
Valade S, Azoulay E, Galicier L, et al. Coagulation disorders and bleedings in critically ill patients with hemophagocytic lymphohistiocytosis [J].
Medicine (Baltimore),
2015,
94(40): e1692.
|
| 25 |
Gando S, Wada H, Thachil J. Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS) [J].
J Thromb Haemost,
2013,
11(5): 826-835.
|
| 26 |
Wada H, Matsumoto T, Yamashita R, et al. Disseminated intravascular coagulation: testing and diagnosis [J].
Clin Chim Acta,
2014,
436: 130-134.
|
| 27 |
Ding R, Wang Z, Lin Y, et al. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with Sepsis 3.0: a retrospective study [J].
Blood Coagul Fibrinolysis,
2018,
29(6): 551-558.
|
| 28 |
Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation [J].
J Intensive Care,
2016,
4: 23.
|
| 29 |
Zou Y, Guo H, Zhang Y, et al. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China [J].
Biosci Trends,
2020,
14(4): 285-289.
|
| 30 |
Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study [J].
Intensive Care Med,
2020,
46(6): 1089-1098.
|
| 31 |
Wada H, Nishioka J, Nobori T, et al. Diagnosis of DIC based on evidence [J].
Rinsho Byori,
2006,
54(11): 1172-1177.
|
| 32 |
Gando S, Saitoh D, Ogura H, et al. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis [J].
Crit Care,
2013,
17(3): R111.
|
| 33 |
Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines [J].
J Intensive Care,
2014,
2(1): 15.
|
| 34 |
Iba T, Arakawa M, Nisio MD, et al. Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt-disseminated intravascular coagulation and predicts high mortality [J].
J Intensive Care Med,
2020,
35(7): 643-649.
|
| 35 |
Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [J].
J Thromb Haemost,
2020,
18(5): 1094-1099.
|
| 36 |
White RH. The epidemiology of venous thromboembolism [J].
Circulation,
2003,
107(23 Suppl 1): I4-8.
|
| 37 |
Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden [J].
Arterioscler Thromb Vasc Biol,
2014,
34(11): 2363-2371.
|
| 38 |
Prichayudh S, Tumkosit M, Sriussadaporn S, et al. Incidence and associated factors of deep vein thrombosis in Thai surgical ICU patients without chemoprophylaxis: one year study [J].
J Med Assoc Thai,
2015,
98(5): 472-478.
|
| 39 |
Kaplan D, Casper TC, Elliott CG, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock [J].
Chest,
2015,
148(5): 1224-1230.
|
| 40 |
Miri M, Goharani R, Sistanizad M. Deep vein thrombosis among intensive care unit patients; an epidemiologic study [J].
Emerg (Tehran),
2017,
5(1): e13.
|
| 41 |
Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients [J].
J Thromb Haemost,
2020,
18(7): 1743-1746.
|
| 42 |
Fogarty H, Townsend L, Cheallaigh CN, et al. More on COVID-19 coagulopathy in Caucasian patients [J].
Br J Haematol,
2020,
189(6): 1060-1061.
|
| 43 |
Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19 [J].
N Engl J Med,
2020,
382(17): e38.
|